Results 1 to 10 of about 384,231 (258)

Expanding the landscape of antibody discovery. [PDF]

open access: yesCell Rep Methods
Library:library screening technologies hold substantial promise for paired antibody:antigen discovery, but challenges have persisted. In this issue of Cell Reports Methods, Wagner et al. introduce a method that combines antibody-ribosome-mRNA complexes, antigen cell surface display, and single-cell RNA sequencing to successfully screen diverse antibody
Johnson S, DeKosky BJ.
europepmc   +4 more sources

A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies [PDF]

open access: yesmAbs, 2021
Hybridoma technology has been valuable in the development of therapeutic antibodies. More recently, antigen-specific B-cell selection and display technologies are also gaining importance. A major limitation of these approaches used for antibody discovery
Ruijun Zhang   +15 more
doaj   +2 more sources

Antibodies, repertoires and microdevices in antibody discovery and characterization. [PDF]

open access: yesLab Chip
Essential in treating numerous diseases, novel therapeutic antibody candidates are needed. This critical review examines recent advances in microdevices and the challenges associated with candidate discovery and characterization.
Schlotheuber LJ, Lüchtefeld I, Eyer K.
europepmc   +5 more sources

Technologies for Monoclonal Antibody Discovery and Development. [PDF]

open access: yesInt J Mol Sci
Monoclonal antibodies (mAbs) represent one of the most successful classes of biopharmaceuticals, with more than 100 approved for treating oncological, immunological, and infectious diseases. Antibody discovery and development have been driven by diverse methodologies.
Han KH   +4 more
europepmc   +3 more sources

The Application of Machine Learning on Antibody Discovery and Optimization. [PDF]

open access: yesMolecules
Antibodies play critical roles in modern medicine, serving as diagnostics and therapeutics for various diseases due to their ability to specifically bind to target antigens. Traditional antibody discovery and optimization methods are time-consuming and resource-intensive, though they have successfully generated antibodies for diagnosing and treating ...
Zheng J, Wang Y, Liang Q, Cui L, Wang L.
europepmc   +4 more sources

Versatile and rapid microfluidics-assisted antibody discovery. [PDF]

open access: yesMAbs, 2021
Recent years have seen unparalleled development of microfluidic applications for antibody discovery in both academic and pharmaceutical research. Microfluidics can support native chain-paired library generation as well as direct screening of antibody secreting cells obtained by rodent immunization or from the human peripheral blood.
Gaa R   +5 more
europepmc   +5 more sources

Dual-target Bridging ELISA for Bispecific Antibodies

open access: yesBio-Protocol, 2022
Bispecific antibodies (BsAbs) are typically monoclonal antibody (mAb)–derived molecular entities engineered to bind to two distinct targets, including two antigens or two epitopes on the same antigen.
Min Pei   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy